These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 1471419)

  • 21. Chinese vaccine products go global: vaccine development and quality control.
    Xu M; Liang Z; Xu Y; Wang J
    Expert Rev Vaccines; 2015 May; 14(5):763-73. PubMed ID: 25697690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lessons learned in shaping vaccine markets in low-income countries: a review of the vaccine market segment supported by the GAVI Alliance.
    Gilchrist SA; Nanni A
    Health Policy Plan; 2013 Dec; 28(8):838-46. PubMed ID: 23174880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The imperative for stronger vaccine supply and logistics systems.
    Zaffran M; Vandelaer J; Kristensen D; Melgaard B; Yadav P; Antwi-Agyei KO; Lasher H
    Vaccine; 2013 Apr; 31 Suppl 2():B73-80. PubMed ID: 23598495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Developing Countries Vaccine Manufacturers' Network (DCVMN) is a critical constituency to ensure access to vaccines in developing countries.
    Jadhav S; Datla M; Kreeftenberg H; Hendriks J
    Vaccine; 2008 Mar; 26(13):1611-5. PubMed ID: 18294742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and technology transfer of Haemophilus influenzae type b conjugate vaccines for developing countries.
    Beurret M; Hamidi A; Kreeftenberg H
    Vaccine; 2012 Jul; 30(33):4897-906. PubMed ID: 22683521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global support for new vaccine implementation in middle-income countries.
    Kaddar M; Schmitt S; Makinen M; Milstien J
    Vaccine; 2013 Apr; 31 Suppl 2():B81-96. PubMed ID: 23598496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccines, global health and social equity.
    Levine MM; Robins-Browne R
    Immunol Cell Biol; 2009; 87(4):274-8. PubMed ID: 19308074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delivering the promise of the Decade of Vaccines: opportunities and challenges in the development of high quality new vaccines.
    Keith JA; Agostini Bigger L; Arthur PA; Maes E; Daems R
    Vaccine; 2013 Apr; 31 Suppl 2():B184-93. PubMed ID: 23598480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Towards a new vaccine economy?].
    Poirot P; Martin JF
    Sante; 1994; 4(3):183-7. PubMed ID: 7921683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The countries' point of view.
    Schatzmayr HG
    Vaccine; 1992; 10(13):954. PubMed ID: 1471419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccine stability in the context of vaccine delivery in a developing country: India.
    John TJ
    Dev Biol Stand; 1996; 87():19-25. PubMed ID: 8853998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccine vial monitor availability and use in low- and middle-income countries: A systematic review.
    Eriksson P; Gessner BD; Jaillard P; Morgan C; Le Gargasson JB
    Vaccine; 2017 Apr; 35(17):2155-2161. PubMed ID: 28364924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Challenges for nationwide vaccine delivery in African countries.
    Songane M
    Int J Health Econ Manag; 2018 Jun; 18(2):197-219. PubMed ID: 29047019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developing Countries Vaccine Manufacturers Network: doing good by making high-quality vaccines affordable for all.
    Pagliusi S; Leite LC; Datla M; Makhoana M; Gao Y; Suhardono M; Jadhav S; Harshavardhan GV; Homma A
    Vaccine; 2013 Apr; 31 Suppl 2():B176-83. PubMed ID: 23598479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.